Company profile for Aitia

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used...
Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
561 Windsor St Somerville, MA 02143
Telephone
Telephone
617.374.2300
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/aitia-and-gustave-roussy-join-forces-to-identify-the-fundamental-biological-causes-of-multiple-human-cancers-302472566.html

PR NEWSWIRE
04 Jun 2025

https://www.prnewswire.com/news-releases/orion-and-aitia-enter-ai-driven-drug-discovery-and-drug-simulation-collaboration-in-oncology-302258493.html

PR NEWSWIRE
25 Sep 2024

https://www.businesswire.com/news/home/20231113943756/en

BUSINESSWIRE
13 Nov 2023

https://www.prnewswire.com/news-releases/charles-river-and-aitia-enter-strategic-agreement-to-utilize-logica-in-discovery-programs-for-neurodegenerative-diseases-and-oncology-301986044.html

PR NEWSWIRE
13 Nov 2023

https://www.prnewswire.com/news-releases/aitia-enters-into-multi-year-ai-driven-drug-discovery-and-drug-simulation-collaboration-with-servier-for-pancreatic-cancer-301827477.html

PR NEWSWIRE
17 May 2023

https://www.prnewswire.com/news-releases/demonstration-of-accurate-screening-of-gene-dependency-in-multiple-myeloma-from-aitias-gemini-digital-twins-to-be-presented-at-2023-aacr-annual-meeting-301794686.html

PR NEWSWIRE
11 Apr 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty